Video

Outcomes of Kennedy Pharmacy Innovation Center's Chronic Care Management Program

Bob Davis, PharmD, FAPhA, a professor of the Kennedy Pharmacy Innovation Center, talks about the center's Chronic Care Management program and its outcomes.

Bob Davis, PharmD, FAPhA, a professor of the Kennedy Pharmacy Innovation Center, talks about the center's Chronic Care Management program and its outcomes.

This video was recorded at APhA's Annual Meeting and Exposition in March 2015.

Related Videos
Related Content
Alzheimer's disease concept, Elderly woman holding brain symbol of missing jigsaw puzzle, World Alzheimer's, World mental health, Memory loss, Dementia, Parkinson disease - Image credit: ipopba | stock.adobe.com
December 24th 2024

Study: Shingles Could Significantly Increase Risk of Dementia and Parkinson Disease

Kennedy Ferruggia, Assistant Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
Doctor holding a coronavirus COVID-19 test tube - Image credit: bizoo_n | stock.adobe.com
December 24th 2024

Understand the Data on COVID-19 Vaccines and Long COVID

Adam James, PharmD
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
December 23rd 2024

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Alexandra Gerlach, Associate Editor
herpes zoster or shingles in woman on her waist , cause of varicella zoster virus infections symptoms of itchy ,rash and raised dots on skin and redness with pain and tingling suffering - Image credit: jaojormami | stock.adobe.com
December 23rd 2024

Researchers Evaluate Pain Management Therapy Intervention to Treat Chronic Postherpetic Neuralgia

Kennedy Ferruggia, Assistant Editor
VICTOZA medication with Liraglutide active substance by Novo Nordisk, used for treatment of diabetes mellitus type 2, weight management, hyperglycemia,injection
Published: December 23rd 2024 | Updated: December 23rd 2024

FDA Approves First Generic of Liraglutide Injection to Lower Blood Sugar in Patients With Type 2 Diabetes

Luke Halpern, Assistant Editor